HYDROCHLOROTHIAZIDE
- Product NDC
- 0615-8449
- 11-digit product format
- 006158449
- Labeler code
- 0615
- Product ID
- 0615-8449_9079c505-b8f7-4c45-9602-d4a9b998d910
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- HYDROCHLOROTHIAZIDE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NCS HealthCare of KY, LLC dba Vangard Labs
- Application
- ANDA040702
- Marketing category
- ANDA
- Marketing start
- 2019-11-01
- Substance
- HYDROCHLOROTHIAZIDE
- Active strength
- 12.5 mg/1
- Pharmacologic classes
- Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| 0J48LPH2TH | HYDROCHLOROTHIAZIDE | 58-93-5 | HYDROCHLOROTHIAZIDE |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 0615-8449-05 | 00615844905 | 15 TABLET in 1 BLISTER PACK (0615-8449-05) | 15 tablet | 2024-07-12 | No | No | Historical |
| 0615-8449-39 | 00615844939 | 30 TABLET in 1 BLISTER PACK (0615-8449-39) | 30 tablet | 2023-03-09 | No | No | Historical |